TABLE 5.
LncRNAs and paclitaxel resistance in ovarian cancer.
| LncRNAs | Expression1 | Genes and pathways | References |
| UCA1 | ↑ | miR-654-5p/SIK2 | Li Z. Y. et al., 2020 |
| miR-129/ABCB1 | Wang J. et al., 2018 | ||
| NEAT1 | ↑ | miR-194/ZEB1 | An et al., 2017 |
| LINC01118 | ↑ | miR-134/ABCC1 | Shi and Wang, 2018 |
| PRLB | ↑ | RSF1/NF-κB | Zhao and Hong, 2021 |
| SNHG22 | ↑ | miR-2467/Gal-1 | Zhang P. F. et al., 2019 |
| FER1L4 | ↓ | MAPK | Liu S. et al., 2018 |
| SNHG5 | ↓ | miR-23a | Lin et al., 2020 |
1LncRNAs either up-regulated (↑) or down-regulated (↓) in paclitaxel resistant ovarian cancer cells. This table shows seven lncRNAs whose expression levels and potential targets in paclitaxel resistance of ovarian cancer.